Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2011 1
2012 5
2013 1
2014 1
2015 1
2017 1
2019 2
2020 3
2021 1
2022 3
2023 3
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Complications of Macular Peeling.
Asencio-Duran M, Manzano-Muñoz B, Vallejo-García JL, García-Martínez J. Asencio-Duran M, et al. J Ophthalmol. 2015;2015:467814. doi: 10.1155/2015/467814. Epub 2015 Sep 3. J Ophthalmol. 2015. PMID: 26425351 Free PMC article. Review.
Role of inflammation in endophthalmitis.
Vallejo-Garcia JL, Asencio-Duran M, Pastora-Salvador N, Vinciguerra P, Romano MR. Vallejo-Garcia JL, et al. Among authors: asencio duran m. Mediators Inflamm. 2012;2012:196094. doi: 10.1155/2012/196094. Epub 2012 Sep 2. Mediators Inflamm. 2012. PMID: 22973073 Free PMC article. Review.
Vitreous diagnosis in neoplastic diseases.
Asencio-Duran M, Vallejo-Garcia JL, Pastora-Salvador N, Fonseca-Sandomingo A, Romano MR. Asencio-Duran M, et al. Mediators Inflamm. 2012;2012:930704. doi: 10.1155/2012/930704. Epub 2012 Sep 26. Mediators Inflamm. 2012. PMID: 23055575 Free PMC article. Review.
Ocular side effects of oncological therapies: Review.
Asencio-Durán M, Fernández-Gutiérrez E, Larrañaga-Cores M, Klein-Burgos C, Dabad-Moreno JV, Capote-Díez M. Asencio-Durán M, et al. Arch Soc Esp Oftalmol (Engl Ed). 2024 Mar;99(3):109-132. doi: 10.1016/j.oftale.2023.11.003. Epub 2023 Nov 9. Arch Soc Esp Oftalmol (Engl Ed). 2024. PMID: 37949110 Review.
Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study.
Ruiz-Medrano J, Udaondo Mirete P, Fernández-Jiménez M, Asencio-Duran M, Fernández-Vigo JI, Medina-Baena M, Flores-Moreno I, Pareja-Esteban J, Touhami S, Giocanti-Aurégan A, Cicinelli MV, Loewenstein A, Ruiz-Moreno JM. Ruiz-Medrano J, et al. Among authors: asencio duran m. Br J Ophthalmol. 2025 Sep 23;109(10):1155-1160. doi: 10.1136/bjo-2024-325665. Br J Ophthalmol. 2025. PMID: 40379451 Free PMC article.
Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! Registry.
Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, Kheir WJ, Kok G, Vujosevic S, O'Toole L, Mangelschots E, Jaross N, Ceklic L, Daien V, Viola F, Squirrell D, Lavid FJ, Creuzot-Garcher C, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group. Mehta H, et al. Ophthalmol Retina. 2024 Sep;8(9):872-879. doi: 10.1016/j.oret.2024.04.008. Epub 2024 Apr 16. Ophthalmol Retina. 2024. PMID: 38615818 Free article.
Brolucizumab clinical and safety outcomes in a neovascular age-related macular degeneration national database: Fight Retinal Blindness Spain (FRB Spain).
Zarranz-Ventura J, Marías-Pérez S, Martin-Pinardel R, Fernandez-Bonet M, Pina-Marin B, Cobos E, Rodríguez-Fernandez CA, Parrado-Carrillo A, Alarcón-Valero I, Barnes C, Cilveti E, Aramburu-Claveria J, Ascaso-Puyuelo FJ, Calvo P, Ruiz-Del-Tiempo MP, Susanna-González G, Figueras-Roca M, Casaroli-Marano RP, Bernal-Morales C; Fight Retinal Blindness Spain (FRB Spain) investigators. Zarranz-Ventura J, et al. Eye (Lond). 2025 Aug;39(12):2407-2414. doi: 10.1038/s41433-025-03871-6. Epub 2025 Jun 5. Eye (Lond). 2025. PMID: 40473932
COVID-19 pandemic: Impact on the rate of viral conjunctivitis.
Conde Bachiller Y, Puente Gete B, Gil Ibáñez L, Esquivel Benito G, Asencio Duran M, Dabad Moreno JV. Conde Bachiller Y, et al. Among authors: asencio duran m. Arch Soc Esp Oftalmol (Engl Ed). 2022 Feb;97(2):63-69. doi: 10.1016/j.oftale.2022.01.001. Epub 2022 Jan 31. Arch Soc Esp Oftalmol (Engl Ed). 2022. PMID: 35152950 Free PMC article.
28 results